146 related articles for article (PubMed ID: 7451634)
1. Determination of ethinylestradiol and norethisterone in an oral contraceptive capsule by reversed-phase high performance liquid chromatography.
Gluck JA; Shek E
J Chromatogr Sci; 1980 Nov; 18(11):631-6. PubMed ID: 7451634
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of ethynodiol diacetate and ethinyl estradiol/mestranol in oral contraceptive tablets by high-performance liquid chromatography.
Carignan G; Lodge BA; Skakum W
J Pharm Sci; 1982 Feb; 71(2):264-6. PubMed ID: 7062257
[TBL] [Abstract][Full Text] [Related]
3. Measurement of ethynylestradiol and levonorgestrel incorporated into sustained release contraceptive formulations.
Iohan F; Jackanicz T; Monder C
Contraception; 1985 Dec; 32(6):571-80. PubMed ID: 3937663
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone.
Stanczyk FZ; Gale JA; Goebelsmann U; Nerenberg C; Matin S
Contraception; 1980 Nov; 22(5):457-70. PubMed ID: 7471737
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
Bowles SM; Mills RJ
Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
[TBL] [Abstract][Full Text] [Related]
6. A proposed method for the determination of the components of an oral contraceptive mixture (norethisterone acetate and ethinyl estradiol).
Belal S; Elnenaey EA
Pharmazie; 1977 Feb; 32(2):125. PubMed ID: 859906
[No Abstract] [Full Text] [Related]
7. Determination of ethynylestradiol and norethindrone in synthetic intestinal fluid and in timed-release oral formulations.
Swynnerton NF; Fischer JB
J Liq Chromatogr; 1980; 3(8):1195-204. PubMed ID: 12278566
[TBL] [Abstract][Full Text] [Related]
8. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
9. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
[TBL] [Abstract][Full Text] [Related]
11. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and biological justifications for the use of Triella].
McGuire JL; Pasquale SA; Castaigne JP
Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
[TBL] [Abstract][Full Text] [Related]
13. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
14. Variability of pharmacokinetic parameters for contraceptive steroids.
Fotherby K
J Steroid Biochem; 1983 Jul; 19(1C):817-20. PubMed ID: 6887900
[TBL] [Abstract][Full Text] [Related]
15. The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.
Orme ML
Br J Clin Pharmacol; 1982 Jul; 14(1):31-42. PubMed ID: 7049209
[TBL] [Abstract][Full Text] [Related]
16. Selection of high-performance liquid chromatographic methods in pharmaceutical analysis. I. Optimization for selectivity in reversed-phase chromatography.
Gazdag M; Szepesi G; Szeleczki E
J Chromatogr; 1988 Nov; 454():83-94. PubMed ID: 3235607
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of ethinylestradiol and levonorgestrel in oral contraceptives by derivative spectrophotometry.
Berzas JJ; Rodríguez J; Castañeda G
Analyst; 1997 Jan; 122(1):41-4. PubMed ID: 9069098
[TBL] [Abstract][Full Text] [Related]
18. Dissolution testing of norethindrone:ethinyl estradiol, norethindrone:mestranol, and norethindrone acetate:ethinyl estradiol combination tablets.
Nguyen HT; Shiu GK; Worsley WN; Skelly JP
J Pharm Sci; 1990 Feb; 79(2):163-7. PubMed ID: 2324966
[TBL] [Abstract][Full Text] [Related]
19. Some aspects of studies with oral contraceptives in Indian women.
Shah PN
J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
[TBL] [Abstract][Full Text] [Related]
20. Analysis of norethindrone in plasma by high-performance liquid chromatography.
Loo JC; Brien R
J Liq Chromatogr; 1981; 4(5):871-7. PubMed ID: 12262593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
